NF-κB p65 is an important amplifier of AD pathogenesis that exerts its effects by binding to the κB elements on the promoter of beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) to increase the expression of β-secretase [73]. Here, NFKB1 is linked to Alzheimer disease.